Effects of mexiletine on electrical field stimulation-induced contractile responses in the ipsilateral and contralateral vasa deferentia after unilateral testicular torsion/detorsion

European Surgical Research

Volumn 38, Issue 4, 2006, Pages 423-429

  Özen, Ibrahim Onur ^a   Vural, Ismail Mert ^a   Moralioǧlu, Serdar ^a   Barun, Süreyya ^a   Ercan, Zeynep Sevim ^a   Sarioǧlu, Yusuf ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Ejaculation; Mexiletine; Noradrenergic transmission; Purinergic transmission; Rabbit vas deferens; Testicular torsion; Vas deferens

Indexed keywords

MEXILETINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ELECTROSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPERMATIC CORD; TESTIS TORSION; VAS DEFERENS;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ELECTRIC STIMULATION; MALE; MEXILETINE; MUSCLE CONTRACTION; RABBITS; SPERMATIC CORD TORSION; VAS DEFERENS;

EID: 33748307757     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094980     Document Type: Article

References (29)

1. Anderson JB, Williamson RC: The fate of the human testes following unilateral torsion of the spermatic cord. Br J Urol 1986;58:698-704.
2. Anderson JB, Williamson RC: Fertility after torsion of the spermatic cord. Br J Urol 1990;65:225-230.
3. Cass AS: Torsion of the testis. Postgrad Med 1990;87:69-70, 73-74.
4. Krarup T: The testes after torsion. Br J Urol 1978;50:43.
5. Anderson JB, Williamson RCN: Testicular torsion in Bristol: a 25-year review. Br J Surg 1988;75:988-992.
6. Anderson MJ, Dunn JK, Lipshultz LI, Coburn M: Semen quality and endocrine parameters after acute testicular torsion. J Urol 1992;147:1545-1550.
7. Turner TT: Acute experimental testicular torsion. No effect on the contralateral testis. J Androl 1985;6:65-72.
8. Visser AJ, Heyns CF: Testicular function after torsion of the spermatic cord. BJU Int 2003;92:200-203.
9. Lee EJ, Ayoub IA, Harris FB, Hassan M, Ogilvy CS, Maynard KI: Mexiletine and magnesium independently, but not combined, protect against permanent focal cerebral ischemia in Wistar rats. J Neurosci Res 1999;58:442-448.
10. Chang CZ, Winardi D, Loh JK, Kung SS, Howng SL, Jeng AY, Kwan AL: Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletine. Acta Neurochir (Wien) 2002;144:189-193.
11. Li H, Xu KY, Zhou L, Kalai T, Zweier JL, Hideg K, Kuppusamy P: A pyrroline derivative of mexiletine offers marked protection against ischemia/reperfusion-induced myocardial contractile dysfunction. J Pharmacol Exp Ther 2000;295:563-571.
12. Niwano S, Inuo K, Morohoshi Y, Nakayama S, Yuge M, Imaki R, Izumi T: Mexiletine protects myocardium during acute ischemia by opening sarcolemmal K-ATP channel: studies in closed-chest acute ischemia model in rabbits. J Cardiovasc Pharmacol 2004;44:639-644.
13. Hewitt KE, Stys PK, Lesiuk HJ: The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury. Brain Res 2001;898:281-287.
14. Ventura S: Autoinhibition, sympathetic cotransmission and biphasic contractile responses to trains of nerve stimulation in the rodent vas deferens. Clin Exp Pharmacol Physiol 1998;25:965-973.
15. Barun S, Ekingen G, Mert Vural I, Turkyilmaz Z, Basaklar C, Kale N, Sevim Ercan Z, Sarioglu Y: The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion. Naunyn Schmiedebergs Arch Pharmacol 2005;371:351-358.
16. Caner H, Can A, Atalay B, Erdogan B, Albayrak AH, Kilinc K, Bavbek M, Altinors N: Early effects of mild brain trauma on the cytoskeletal proteins neurofilament 160 and MAP2, and the preventive effects of mexiletine. Acta Neurochir (Wien) 2004;146:611-621.
17. Demirpence E, Caner H, Bavbek M, Kilinc K: Antioxidant action of the antiarrhythmic drug mexiletine in brain membranes. Jpn J Pharmacol 1999;81:7-11.
18. Labbe L, Turgeon J: Clinical pharmacokinetics of mexiletine. Clin Pharmacokinet 1999;37:361-384.
19. Yaris E, Kesim M, Kadioglu M, Kalyoncu NI, Ulku C, Ozyavuz R: The effects of paroxetine on rat isolated vas deferens. Pharmacol Res 2003;48:335-345.
20. Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ: Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 2000;403:86-89.
21. Sneddon P, Machaly M: Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol 1992;12:421-428.
22. Ozturk Y, Aydin S: Effects of streptozotocin-induced diabetes and insulin on calcium responsiveness of the rat vas deferens. Life Sci 2006;78:1084-1090.
23. Eiserich JP, Patel RP, O'Donnell VB: Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 1998;19:221-357.
24. Akgur FM, Kilinc K, Aktug T: Reperfusion injury after detorsion of unilateral testicular torsion. Urol Res 1993;21:395-399.
25. Toth A, Halmosi R, Kovacs K, Deres P, Kalai T, Hideg K, Toth K, Sumegi B: Akt activation induced by an antioxidant compound during ischemia-reperfusion. Free Radic Biol Med 2003;35:1051-1063.
26. Tanyel FC, Buyukpamukcu N, Hicsonmez A: Contralateral testicular blood flow during unilateral testicular torsion. Br J Urol 1989;63:522-524.
27. Akgur FM, Kilinc K, Aktug T: Is ipsilateral testis mandatory for the occurrence of contralateral intratesticular biochemical changes indicative of hypoxia after unilateral spermatic cord torsion? Eur Urol 1995;28:143-146.
28. Kang JX, Li Y, Leaf A: Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n-3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1997,94:2724-2728.
29. Taouis M, Sheldon RS, Duff HJ: Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug. J Clin Invest 1991;88:375-378.